REVVITY, INC Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax
REVVITY, INC (RVTY) reported Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax of $4.80 million for the 12-month period ending 2013-12-29, per its 10-K filed 2016-03-01.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesBeforeTax · last filed 2016-03-01
- REVVITY, INC other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for the quarter ending 2013-12-29 was $6.30M.
- REVVITY, INC other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for the quarter ending 2013-09-29 was -$500.00K.
- REVVITY, INC other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for the quarter ending 2013-06-30 was -$500.00K.
- REVVITY, INC other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for the quarter ending 2013-03-31 was -$500.00K.
- REVVITY, INC other comprehensive income (loss), reclassification adjustment from aoci on derivatives, before tax for fiscal 2013 was $4.80M.
| Period end | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 3 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 6 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 9 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 12 month | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI on Derivatives, before Tax 12 month as first filed |
|---|---|---|---|---|---|
| 2013-12-29 | $6.30M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-01 | $5.80M derived: sum of 2 quarters · filed 2016-03-01 | $5.30M derived: sum of 3 quarters · filed 2016-03-01 | $4.80M 10-K · filed 2016-03-01 | -$4.80M 10-K · filed 2014-02-25 |
| 2013-09-29 | -$500.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$1.00M derived: sum of 2 quarters · filed 2014-11-04 | -$1.50M 10-Q · filed 2014-11-04 | ||
| 2013-06-30 | -$500.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$1.00M 10-Q · filed 2014-08-05 | |||
| 2013-03-31 | -$500.00K 10-Q · filed 2014-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |